Third, as a transitional product for people coming off GLP-1 medications who want to maintain some level of metabolic support
According to Nature, the drug is predicted to be available in 2027
Janet Tomiyama, PhD, a health psychologist at the University of California, Los Angeles, wrote in a 2025 commentary, (GLP-1s) have the potential to increase weight stigma, medicalize larger bodies, and shame people for both taking the perceived easy way outor not taking it
Health Conditions Alleged in Ozempic Lawsuits Some people who have filed lawsuits claim that they experienced the following issues because they took Ozempic or other GLP-1 drugs: Bowel obstruction Ileus Pulmonary aspiration Biliary diseases Gallbladder problems that required removal surgery Gastroparesis Pancreatitis Vision loss or problems Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) These and other health conditions are being investigated in the Ozempic litigation
It does not sterilize a contaminated solution
Lets not discredit my years of working out, Kardashian wrote